This is a news story, published by PBS, that relates primarily to APOE4 news.
For more disease research news, you can click here:
more disease research newsFor more news from PBS, you can click here:
more news from PBSOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like disease research news, you might also like this article about
Alzheimer. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest European Alzheimer news, life Alzheimer news, disease research news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
initial AlzheimerPBS
•74% Informative
Researchers have identified a genetic form of late-in-life Alzheimer’s disease — in people who inherit two copies of a worrisome gene.
Symptoms can begin seven to 10 years sooner than in other older adults who develop the disease.
Scientists say the research makes it critical to develop treatments that target the APOE4 gene.
The drug Leqembi works by clearing away some sticky amyloid.
It’s not clear if carriers of two APOE4 genes benefit because they have such a high risk of a side effect from the drug dangerous brain swelling and bleeding.
Masliah said other research aims to develop gene therapy or drugs to specifically target APoe4 .
VR Score
85
Informative language
90
Neutral language
52
Article tone
semi-formal
Language
English
Language complexity
41
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links